At its core, the cream features a blend of five calming botanical extracts, including centella asiatica, totarol, madecassoside and asiaticoside, chosen for their proven anti-inflammatory and regenerative properties. These are complemented by eight nourishing natural oils, which contribute to deep hydration and barrier reinforcement, making the product suitable even for highly sensitive or infant skin.

Further strengthening the formulation are potent actives such as phytosphingosine, known for its steroid-like anti-inflammatory action without associated side effects, along with bisabolol, panthenol and glycerin. Together, these ingredients help restore skin elasticity, reduce discomfort and support long-term resilience. A bionic cuticular structure ensures controlled, efficient delivery of active compounds, enhancing their bioavailability and effectiveness.

The product is hypoallergenic, fragrance-free and free from parabens and steroids, and has been rigorously tested under clinical conditions. It has also received the Seal of Acceptance from the National Eczema Association, underscoring its suitability for sensitive and atopic skin at all ages.

Combining clinical efficacy, skin tolerance and a refined natural formulation, this treatment meets the level of excellence associated with the Jury Prize.